Q2
DRIO — Q2 2026 Financial Report Analysis
DarioHealth's Q2 2026 net loss narrowed 39% to $7.9M on 20% lower operating costs, but revenue fell 3.6% to $5.2M as business-customer sales dropped 29%, and cash fell to about $14M before a $22.8M July raise.